Centro de Investigaciones Médicas Tucumán
Centro de Investigaciones Médicas Tucumán
Lavalle 506, T4000 San Miguel de Tucumán, Tucumán, Argentina
Select an option
I am a doctor
I am a sponsor
Our team
Medical staff
Victor Pastrana
Paula Corbalán
Horacio Berman
Jorge Gustavo José
Alberto Jorge Spindler
Walter Spindler
Eduardo Ezequiel Martínez
Alberto Berman
Nicolás Destefani Villafañe
Pamela Giorgis
Maria Alejandra Herrera
Maria Florencia Montesinos
Natalia Ruiz
María Julia Periillo
Analia Puparelli
Noemi Costilla
Legal and Administrative staff
Study Coordinator Lorena Diaz Cordoba
Open studies
Lupus
Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis - IRIS - AstraZenecaSee more
Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus - APATURA - SanofiSee more
A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus - AMETHYST - BiogenSee more
Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2) - SIRIUS-SLE 2 - Novartis PharmaceuticalsSee more
A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus - OPUS-1 - Idorsia Pharmaceuticals Ltd.See more
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus - PHOENYCS FLY - UCB Biopharma SRLSee more
A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE) - Immunovant Sciences GmbHSee more
Rare diseases
A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome - POETYK SjS-1 - Bristol-Myers SquibbSee more
A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome - Unity - argenxSee more
Nipocalimab in Moderate to Severe Sjogren's Disease - DAFFODIL - Janssen Research & Development, LLCSee more
Arthritis
A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis - JUVE-X - Eli Lilly and CompanySee more
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced Participants With Active Psoriatic Arthritis - ICONIC-PsA 2 - Janssen Research & Development, LLCSee more
Breast Cancer
A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02) - DYNASTY-Breast02 - BioNTech SESee more
Myasthenia gravis
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad) - MyClad - EMD Serono Research & Development Institute, Inc.See more
Obesity
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2) - SURMOUNT-ADOLESCENTS-2 - Eli Lilly and CompanySee more
Urticaria
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria - EMBARQ-CSU1 - Celldex TherapeuticsSee more
